These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9349423)

  • 1. Bridging the 'commercialisation gap' in Europe.
    Martin PA
    Gene Ther; 1997 Sep; 4(9):881-2. PubMed ID: 9349423
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceutical research: cost savings through innovation.
    Cohen KR; Levy RA
    AAPPO J; 1993 Oct; 3(5):28-36. PubMed ID: 10146463
    [No Abstract]   [Full Text] [Related]  

  • 3. National Heart, Lung, and Blood Institute resources and programs for gene therapy in heart, lung, and blood diseases.
    Skarlatos SI
    Circ Res; 2007 Jun; 100(12):1667-9. PubMed ID: 17585073
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapy rising?
    Hoag H
    Nature; 2005 May; 435(7041):530-1. PubMed ID: 15917820
    [No Abstract]   [Full Text] [Related]  

  • 5. NIH funding of gene therapy trials.
    Williams DA
    Mol Ther; 2006 Nov; 14(5):607. PubMed ID: 16979942
    [No Abstract]   [Full Text] [Related]  

  • 6. Somatic gene therapy. Present situation and future perspective.
    Gottschalk U; Chan S
    Arzneimittelforschung; 1998 Nov; 48(11):1111-20. PubMed ID: 9850435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology, medicine & health, Part 3. Therapeutics for tomorrow.
    Davidson SN
    Healthc Forum J; 1995; 38(1):52-60. PubMed ID: 10154288
    [No Abstract]   [Full Text] [Related]  

  • 8. Think royalties, not caps.
    Nat Biotechnol; 1998 Jul; 16(7):595. PubMed ID: 9661166
    [No Abstract]   [Full Text] [Related]  

  • 9. Stakeholders' conference sharpens focus on challenges of clinical gene transfer.
    High KA
    Mol Ther; 2005 Oct; 12(4):581-2. PubMed ID: 16140585
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene therapy for rare diseases.
    Nat Genet; 1999 Aug; 22(4):313-4. PubMed ID: 10431225
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug discovery.
    Kennedy D
    Science; 2004 Mar; 303(5665):1729. PubMed ID: 15031461
    [No Abstract]   [Full Text] [Related]  

  • 12. The increasing opacity of gene therapy.
    Nature; 1999 Nov; 402(6758):107. PubMed ID: 10646989
    [No Abstract]   [Full Text] [Related]  

  • 13. The future of gene therapy.
    Cavazzana-Calvo M; Thrasher A; Mavilio F
    Nature; 2004 Feb; 427(6977):779-81. PubMed ID: 14985734
    [No Abstract]   [Full Text] [Related]  

  • 14. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 15. The Parenteral Drug Association Foundation for Pharmaceutical Sciences: past, present, and future.
    Kirsch NC
    J Parenter Sci Technol; 1989; 43(4):191-4. PubMed ID: 2769528
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene therapy investigations proliferate.
    Hollon T
    Nat Med; 2000 Mar; 6(3):235. PubMed ID: 10700200
    [No Abstract]   [Full Text] [Related]  

  • 17. BIO 2006 Annual International Convention. Innovations in biotech in China and Italy.
    Tear S; Zarkowska T
    IDrugs; 2006 Jun; 9(6):386-9. PubMed ID: 16752303
    [No Abstract]   [Full Text] [Related]  

  • 18. Policy of the American Society of Gene Therapy on financial conflict ofinterest in clinical research.
    Woo SL
    Mol Ther; 2000 May; 1(5 Pt 1):383-4. PubMed ID: 10979736
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene therapy finds welcoming environment in China.
    Jia H
    Nat Med; 2006 Mar; 12(3):263-4. PubMed ID: 16520760
    [No Abstract]   [Full Text] [Related]  

  • 20. Europe urged to provide boost for bioterror research.
    Abbott A
    Nature; 2002 Dec; 420(6915):450. PubMed ID: 12466800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.